1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Immuno-Oncology Diagnostics Market Revenue
• 1.4 Market Analysis by Type
• 1.5 Market by Application
  • 1.5.1 Global Immuno-Oncology Diagnostics Market Share by Application: 2022 VS 2029
• 1.6 Coronavirus Disease 2019 (Covid-19) Impact: Immuno-Oncology Diagnostics Market
  • 1.6.1 How the Covid-19 is Affecting the Immuno-Oncology Diagnostics Market
    • 1.6.1.1 Immuno-Oncology Diagnostics Market Business Impact Assessment - Covid-19
  • 1.6.2 Market Trends and Immuno-Oncology Diagnostics Market Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Immuno-Oncology Diagnostics Market Perspective (2016-2029)
• 2.2 Immuno-Oncology Diagnostics Market Growth Trends by Regions
  • 2.2.1 Immuno-Oncology Diagnostics Market Size by Regions: 2016 VS 2022 VS 2029
  • 2.2.2 Immuno-Oncology Diagnostics Market Historic Market Share by Regions (2016-2022)
  • 2.2.3 Immuno-Oncology Diagnostics Market Forecasted Market Size by Regions (2022-2029)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porters Five Forces Analysis
  • 2.3.5 Immuno-Oncology Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Immuno-Oncology Diagnostics Market Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Immuno-Oncology Diagnostics Market Players by Market Size
  • 3.1.1 Global Top Immuno-Oncology Diagnostics Market Players by Revenue (2016-2022)
  • 3.1.2 Global Immuno-Oncology Diagnostics Market Revenue Market Share by Players (2016-2022)
  • 3.1.3 Global Immuno-Oncology Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Immuno-Oncology Diagnostics Market Concentration Ratio
  • 3.2.1 Global Immuno-Oncology Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Diagnostics Market Revenue in 2019
• 3.3 Immuno-Oncology Diagnostics Market Key Players Head office and Area Served
• 3.4 Key Players Immuno-Oncology Diagnostics Market Product Solution and Service
• 3.5 Date of entering into Immuno-Oncology Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2029)

• 4.1 Global Immuno-Oncology Diagnostics Market Historic Market Size by Type (2016-2022)
• 4.2 Global Immuno-Oncology Diagnostics Market Forecasted Market Size by Type (2022-2029)

5 Immuno-Oncology Diagnostics Market Breakdown Data by Application (2016-2029)

• 5.1 Global Immuno-Oncology Diagnostics Market Size by Application (2016-2022)
• 5.2 Global Immuno-Oncology Diagnostics Market Forecasted Market Size by Application (2022-2029)

6 North America

• 6.1 North America Immuno-Oncology Diagnostics Market Size (2016-2022)
• 6.2 Immuno-Oncology Diagnostics Market Key Players in North America (2019-2022)
• 6.3 North America Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 6.4 North America Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

7 Europe

• 7.1 Europe Immuno-Oncology Diagnostics Market Size (2016-2022)
• 7.2 Immuno-Oncology Diagnostics Market Key Players in Europe (2019-2022)
• 7.3 Europe Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 7.4 Europe Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

8 China

• 8.1 China Immuno-Oncology Diagnostics Market Size (2016-2022)
• 8.2 Immuno-Oncology Diagnostics Market Key Players in China (2019-2022)
• 8.3 China Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 8.4 China Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

9 Japan

• 9.1 Japan Immuno-Oncology Diagnostics Market Size (2016-2022)
• 9.2 Immuno-Oncology Diagnostics Market Key Players in Japan (2019-2022)
• 9.3 Japan Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 9.4 Japan Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

10 Southeast Asia

• 10.1 Southeast Asia Immuno-Oncology Diagnostics Market Size (2016-2022)
• 10.2 Immuno-Oncology Diagnostics Market Key Players in Southeast Asia (2019-2022)
• 10.3 Southeast Asia Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 10.4 Southeast Asia Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

11 India

• 11.1 India Immuno-Oncology Diagnostics Market Size (2016-2022)
• 11.2 Immuno-Oncology Diagnostics Market Key Players in India (2019-2022)
• 11.3 India Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 11.4 India Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

12 Central & South America

• 12.1 Central & South America Immuno-Oncology Diagnostics Market Size (2016-2022)
• 12.2 Immuno-Oncology Diagnostics Market Key Players in Central & South America (2019-2022)
• 12.3 Central & South America Immuno-Oncology Diagnostics Market Size by Type (2016-2022)
• 12.4 Central & South America Immuno-Oncology Diagnostics Market Size by Application (2016-2022)

13 Key Players Profiles

• 13.1 Company Details
• 13.2 Business Overview and Its Total Revenue
• 13.3 Immuno-Oncology Diagnostics Market Introduction
• 13.4 Immuno-Oncology Diagnostics Market Business (2016-2022)
• 13.5 Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

"Global Immuno-Oncology Diagnostics Market Research Report 2021-2027
The Global Immuno-Oncology Diagnostics Market 2021 Research Report is a professional and in-depth study on the current state of the Immuno-Oncology Diagnostics Market industry. This report provides detailed information on the Immuno-Oncology Diagnostics market, based on logical and insightful information.

The regional description analyzes and forecasts the Immuno-Oncology Diagnostics market at the global levels, covering the key regions for growth. The Immuno-Oncology Diagnostics Market Report analyzes the scope for growth in the market in different regions. The report covers the regions of North America, Latin America, Asia-Pacific, Europe, the Middle East and Africa. The report additionally covers the key areas for growth present in these regional markets, where the companies entering the Immuno-Oncology Diagnostics market must focus for growth.

The report in contrast to the analysis of the key players, provides insights into the competitive landscape of the Immuno-Oncology Diagnostics market, along with analyzing the investment opportunities for the market participants and entrants.

Immuno-Oncology Diagnostics market report analyzes what are the factors that are driving the growth of the Immuno-Oncology Diagnostics market and the factors that are restricting the growth. The report deeply analyzes the volume trends, value of the market, pricing history, etc. which would help the companies entering the Immuno-Oncology Diagnostics market to understand the growth opportunities and threats that are present in the market. A number of opportunities for investment in the Immuno-Oncology Diagnostics market are discovered by analysts and are discussed in this report.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

KEY PLAYERS engaged in the Immuno-Oncology Diagnostics market include
10x Genomics, Inc.
Abbott Diagnostics
AccuraGen Inc.
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience, Inc
Agilent/Dako
Anchor Dx
ANGLE plc
ApoCell, Inc.
ARUP Laboratories
Asuragen
AVIVA Biosciences
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocartis
Biocept, Inc.
Biodesix Inc.
BioFluidica
BioGenex
BioIVT
Biolidics Ltd
bioMérieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc.
Bio-Reference Laboratories
Bio-Techne
Bioview
Bolidics
Boreal Genomics
Bristol-Myers Squibb
Burning Rock
Cancer Genetics
Caris Molecular Diagnostics
Castle Biosciences, Inc.
CellMax Life
Cepheid (Danaher)
Charles River Laboratories
Chronix Biomedical
Circulogene
Clinical Genomics
Cynvenio
Cytolumina Technologies Corp.
CytoTrack
Datar Cancer Genetics Limited
Diagnologix LLC
Diasorin S.p.A.
Enzo Biochem
Epic Sciences
Epigenomics AG
Eurofins Scientific
Exosome Diagnostics
Exosome Sciences
Fabric Genomics
Fluidigm Corp
Fluxion Biosciences
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
GeneFirst Ltd.
Genetron Holdings
GenomOncology
GILUPI Nanomedizin
Grail, Inc.
Guardant Health
HalioDx
HansaBiomed
HeiScreen
Helomics
Horizon Discovery
HTG Molecular Diagnostics
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Invitae Corporation
Invivogen
Invivoscribe
Janssen Diagnostics
MDNA Life SCIENCES, Inc.
MDx Health
Menarini Silicon Biosystems
Millipore Sigma
Miltenyi Biotec
MIODx
miR Scientific
Molecular MD
MyCartis
Myriad Genetics/Myriad RBM
NantHealth, Inc.
Natera
NeoGenomics
New Oncology
NGeneBio
Novogene Bioinformatics Technology Co., Ltd.
Oncocyte
OncoDNA
Ortho Clinical Diagnostics
Oxford Nanopore Technologies
Panagene
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Qiagen Gmbh
Rarecells SAS
RareCyte
Roche Molecular Diagnostics
Screencell
Sense Biodetection
Serametrix
Siemens Healthineers
Silicon Biosystems
simfo GmbH
Singlera Genomics Inc.
Singulomics
SkylineDx
Stratos Genomics
Sysmex Inostics
Tempus Labs, Inc.
Thermo Fisher Scientific Inc.
Thrive Earlier Detection
Todos Medical
Trovagene
Volition
Vortex Biosciences
The report firstly introduced the Immuno-Oncology Diagnostics market basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The report includes six parts, dealing with:
1) Basic information
2) The Asia Immuno-Oncology Diagnostics market.
3) The North American Immuno-Oncology Diagnostics industry.
4) The European Immuno-Oncology Diagnostics industry.
5) Market entry and investment feasibility.
6) The report conclusion."